chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching on the left foot; A spontaneous report was received from a consumer concerning a female patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events itching on the left foot/pruritus.  The patient's medical history was not provided. Concomitant medications reported were Multivitamin, Vitamin B12, Vitamin D, paracetamol, fish oil for drug use for unknown indication.  On 21 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection. On 18 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 022m20A) via unknown route for prophylaxis of COVID-19 infection.  On 21 Jan 2021, the patient experienced the event itching on the left foot.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, itching on the left foot was unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pre-existing condition improved, Pruritus, Rash
Clinical narrative: Improvement of rash (that was present for years); itching; The rash completely disappeared; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching) and RASH (The rash completely disappeared) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 015M20A) for COVID-19 vaccination.     The patient's past medical history included Leukemia and Rash (Rash from the leukemia for several years. After he received the 1st dose of the Moderna Covid-19 vaccine, the rash started to improved and stop itching. The rash completely disappeared 4 - 5 days after receiving the 2nd dose of the vaccine.).   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PRURITUS (itching) and RASH (The rash completely disappeared). At the time of the report, PRURITUS (itching) and RASH (The rash completely disappeared) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow up information received  21-JUN-2021 contain Race information of patient.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site lymphadenopathy, Vaccination site pain, Vaccination site swelling
Clinical narrative: Swelling of my lymph nodes in the injection area; Tender/Hurts when I touch; Looks like a ball; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (Swelling of my lymph nodes in the injection area), VACCINATION SITE PAIN (Tender/Hurts when I touch) and VACCINATION SITE SWELLING (Looks like a ball) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included LISINOPRIL and SIMVASTATIN for an unknown indication.  On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Swelling of my lymph nodes in the injection area), VACCINATION SITE PAIN (Tender/Hurts when I touch) and VACCINATION SITE SWELLING (Looks like a ball). At the time of the report, VACCINATION SITE LYMPHADENOPATHY (Swelling of my lymph nodes in the injection area), VACCINATION SITE PAIN (Tender/Hurts when I touch) and VACCINATION SITE SWELLING (Looks like a ball) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Nausea, Vomiting
Clinical narrative: slight headache; weakness; nausea; Vomiting; chills; This spontaneous case was reported by a physician and describes the occurrence of ASTHENIA (weakness), NAUSEA (nausea), VOMITING (Vomiting), CHILLS (chills) and HEADACHE (slight headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy, Allergy to antibiotic, Asthma, Hypertension and Hyperlipidemia (Patient was taken off Statin). Concomitant products included TRAZODONE, VITAMIN C [ASCORBIC ACID], VITAMIN D NOS and MELOXICAM for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced ASTHENIA (weakness), NAUSEA (nausea), VOMITING (Vomiting) and CHILLS (chills). On 03-Feb-2021, the patient experienced HEADACHE (slight headache). On 28-Jan-2021, ASTHENIA (weakness), NAUSEA (nausea), VOMITING (Vomiting) and CHILLS (chills) had resolved. On 03-Feb-2021, HEADACHE (slight headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was provided.  Patient's concomitant medication includes Bico 100 mg/25 mg   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow up received contains significant information: Concomitant medication added, Medical history updated, Patient race and height added, Second dose information added.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was Reported.     On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  Treatment details included Tylenol.   This case was linked to MOD-2021-016866, MOD-2021-016843 (Patient Link).  This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was Reported.     On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  Treatment details included Tylenol.   This case was linked to MOD-2021-016866, MOD-2021-016843 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Extremely itcy rash at injection site; Extremely itcy rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Extremely itcy rash at injection site) and VACCINATION SITE RASH (Extremely itcy rash at injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medication history was provided.  Concomitant products included IPRATROPIUM BROMIDE (IPRATROPIUM [IPRATROPIUM BROMIDE]) for Allergy, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), CALCIUM, BIOTIN, CHOLESTYRAMINE, ESCITALOPRAM OXALATE (LEXAPRO), FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and LEVOSALBUTAMOL TARTRATE (XOPENEX HFA) for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Extremely itcy rash at injection site) and VACCINATION SITE RASH (Extremely itcy rash at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site pruritus and Vaccination site rash, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PRURITUS (Extremely itcy rash at injection site) and VACCINATION SITE RASH (Extremely itcy rash at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication include hydrocortisone cream  for Vaccination site pruritus and rash.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: email address updated. On 14-Jun-2021: Dose 2 events have been reported.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: early pregnancy after receiving the second dose of the moderna vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (early pregnancy after receiving the second dose of the moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (early pregnancy after receiving the second dose of the moderna vaccine). At the time of the report, EXPOSURE DURING PREGNANCY (early pregnancy after receiving the second dose of the moderna vaccine) outcome was unknown.            Concomitant product use was not provided by the reporter   Treatment information was not provided.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Eczema, Pain in extremity
Clinical narrative: Rash diagnosed as eczema by dermatologist; Soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in her arm) and ECZEMA (Rash diagnosed as eczema by dermatologist) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis and Cold. Concomitant products included IBUPROFEN (ADVIL ARTHRITIS PAIN) for Arthritis, VITAMIN D3 for Cold, RALOXIFENE HYDROCHLORIDE (EVISTA), HYDROCHLOROTHIAZIDE, TRIAMTERENE (DYAZIDE) and CITRA CALCEMIN for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Soreness in her arm). On an unknown date, the patient experienced ECZEMA (Rash diagnosed as eczema by dermatologist). On 27-Jan-2021, PAIN IN EXTREMITY (Soreness in her arm) had resolved. At the time of the report, ECZEMA (Rash diagnosed as eczema by dermatologist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported in follow up that the original side effects that were previously reported by the agents were incorrect and the patient did not experience it back then.   This case was linked to MOD-2021-211533 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Non-significant Follow up, address updated On 03-Aug-2021: Significant follow up received. Additional event of eczema was added and deletion of previous events of sneezing, runny nose, feeling like a cold.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: He was too hot / fever/Fever of Max 103.9; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (He was too hot / fever/Fever of Max 103.9) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012620A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Cholesterol, Diabetes, HIV infection NOS, Kidney disorder (The Stage 3 Kidney Disease) and Triglycerides.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced PYREXIA (He was too hot / fever/Fever of Max 103.9). The patient was treated with ACETYLSALICYLIC ACID (BABY ASPIRIN) ongoing since an unknown date at a dose of UNK dosage form. On 08-Feb-2021, PYREXIA (He was too hot / fever/Fever of Max 103.9) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, Body temperature: 102 (High) High, 103 (High) After half an hour his temperature was 103., 103.9 (High) half an hour later 103.9 and 102 (High) he took a cold shower and his temperature was back on 102.. On 08-Feb-2021, Body temperature: 98.2 (Inconclusive) the fever had dropped down to 98.2..         Concomitant medications include BP medication, Cholesterol medication, Triglyceride medication, Diabetes medication, HIV medication, Kidney disease medications.   Most recent FOLLOW-UP information incorporated above includes: On 03-Apr-2021: TCR Document Received contains no significant information. On 26-Jul-2021: Follow up contains No significant information.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain
Clinical narrative: redness under the armpit; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness) and ERYTHEMA (redness under the armpit) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN (soreness). On 02-Feb-2021, the patient experienced ERYTHEMA (redness under the armpit). At the time of the report, PAIN (soreness) and ERYTHEMA (redness under the armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site erythema, Vaccination site warmth
Clinical narrative: injection site warm to the touch; white areas around injection area; redness around injection site; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE WARMTH (injection site warm to the touch), VACCINATION SITE DISCOLOURATION (white areas around injection area) and VACCINATION SITE ERYTHEMA (redness around injection site) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE WARMTH (injection site warm to the touch), VACCINATION SITE DISCOLOURATION (white areas around injection area) and VACCINATION SITE ERYTHEMA (redness around injection site). At the time of the report, VACCINATION SITE WARMTH (injection site warm to the touch), VACCINATION SITE DISCOLOURATION (white areas around injection area) and VACCINATION SITE ERYTHEMA (redness around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Apr-2021: No new information
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O11M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced DIZZINESS (Dizzy). At the time of the report, DIZZINESS (Dizzy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient felt dizzy after 36 hours of the vaccine. Patient stated that he is using other medication.  No Treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: No specific follow-up information recorded. NNI
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: mild body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (mild body aches) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (mild body aches). At the time of the report, MYALGIA (mild body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Pain, Pain in extremity
Clinical narrative: sore arm; body ache; weakness; fever; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PAIN (body ache), ASTHENIA (weakness), PYREXIA (fever) and HEADACHE (headache) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PAIN (body ache), ASTHENIA (weakness), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (sore arm), PAIN (body ache), ASTHENIA (weakness), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills) outcome was unknown.            No concomitant medication use was provided by the reporter. Treatment of events was not reported.    Reporter did not allow further contact
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: sore arm; body ache; weakness; fever; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PAIN (body ache), ASTHENIA (weakness), PYREXIA (fever) and HEADACHE (headache) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PAIN (body ache), ASTHENIA (weakness), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (sore arm), PAIN (body ache), ASTHENIA (weakness), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills) outcome was unknown.            No concomitant medication use was provided by the reporter. Treatment of events was not reported.    Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, SARS-CoV-2 antibody test
Clinical narrative: Patient stated that she is on chemotherapy and her body didn't respond to the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST (Patient stated that she is on chemotherapy and her body didn't respond to the vaccine) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history not reported).   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 ANTIBODY TEST (Patient stated that she is on chemotherapy and her body didn't respond to the vaccine). At the time of the report, SARS-COV-2 ANTIBODY TEST (Patient stated that she is on chemotherapy and her body didn't respond to the vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Antibody test: low (Low) 40.         Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: FUP received  included no new information.; Reporter's Comments: This report refers to a case of Antibody test after mRNA-1273 vaccination with no associated AEs.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Right eye blurred vision; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Right eye blurred vision) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Migraine headache, Hypertension, Parkinson's disease and Seizure. Concomitant products included METOPROLOL for Hypertension.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced VISION BLURRED (Right eye blurred vision). At the time of the report, VISION BLURRED (Right eye blurred vision) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: injection site rash; injections site warmth; itching at the injection site; This spontaneous case was reported by an other and describes the occurrence of INJECTION SITE PRURITUS (itching at the injection site), INJECTION SITE RASH (injection site rash) and INJECTION SITE WARMTH (injections site warmth) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced INJECTION SITE PRURITUS (itching at the injection site). On 26-Jan-2021, the patient experienced INJECTION SITE RASH (injection site rash) and INJECTION SITE WARMTH (injections site warmth). At the time of the report, INJECTION SITE PRURITUS (itching at the injection site), INJECTION SITE RASH (injection site rash) and INJECTION SITE WARMTH (injections site warmth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Myocarditis, Troponin T increased
Clinical narrative: Myopericarditis - chest pain started 3d after dose #2 of Pfizer COVID-19 vaccine
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Computerised tomogram, Electrocardiogram, Magnetic resonance imaging, VIth nerve paralysis
Clinical narrative: CAUSED PALSY OF THE # 6 LEFT CRANIAL NERVE
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No reaction occurred.  The patient received the dose 8 days prior to the 4 weeks.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Rhinorrhoea, SARS-CoV-2 test, Sneezing
Clinical narrative: Only has a cough; Sneezing; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and COUGH (Only has a cough) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included OMEPRAZOLE, MAGNESIUM OXIDE, CALCIUM CARBONATE, COLECALCIFEROL (CALCIUM WITH VITAMIN D 3) and CYANOCOBALAMIN (B12-VITAMIN) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced SNEEZING (Sneezing) and RHINORRHOEA (Runny nose). On 19-Feb-2021, the patient experienced COUGH (Only has a cough). At the time of the report, SNEEZING (Sneezing) and RHINORRHOEA (Runny nose) had resolved and COUGH (Only has a cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, SARS-CoV-2 test: unknown (Positive) COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant included high blood pressure medication were noted. Treatment details was reported as corsidone for cough and cold. Reporter stated that patient took second dose vaccine at the end of February was noted.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Follow up received included Second dose information provided by the reporter. Corrections made on initial, lab data added, lab investigation removed from the event tab
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Acne, Pain, Peripheral swelling, Swelling, Tenderness
Clinical narrative: felt like he had an ingrown hair or pimple under his arm; tender; lymph node was swollen; swollen on the crease of arm,  under the arm pit, back of his arm; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness), ACNE (felt like he had an ingrown hair or pimple under his arm), TENDERNESS (tender), SWELLING (lymph node was swollen) and PERIPHERAL SWELLING (swollen on the crease of arm,  under the arm pit, back of his arm) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medical history reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN (soreness). On 18-Feb-2021, the patient experienced ACNE (felt like he had an ingrown hair or pimple under his arm), TENDERNESS (tender), SWELLING (lymph node was swollen) and PERIPHERAL SWELLING (swollen on the crease of arm,  under the arm pit, back of his arm). At the time of the report, PAIN (soreness), ACNE (felt like he had an ingrown hair or pimple under his arm), TENDERNESS (tender), SWELLING (lymph node was swollen) and PERIPHERAL SWELLING (swollen on the crease of arm,  under the arm pit, back of his arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia, Swelling
Clinical narrative: Low grade fever; Fatigue; Body aches; Chills; Swelling on the juncture of neck/shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever), FATIGUE (Fatigue), MYALGIA (Body aches), CHILLS (Chills) and SWELLING (Swelling on the juncture of neck/shoulder) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.   On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Low grade fever), FATIGUE (Fatigue), MYALGIA (Body aches), CHILLS (Chills) and SWELLING (Swelling on the juncture of neck/shoulder). At the time of the report, PYREXIA (Low grade fever), FATIGUE (Fatigue), MYALGIA (Body aches), CHILLS (Chills) and SWELLING (Swelling on the juncture of neck/shoulder) outcome was unknown. Not Provided    No relevant concomitant medications were reported.  Treatment was not provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Body temperature, Chest X-ray, Chills
Clinical narrative: Fever of 102 degrees F; Pain in joints; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 102 degrees F), ARTHRALGIA (Pain in joints), HEADACHE (Headache), CHILLS (Chills) and COVID-19 (my adverse reaction was like having covid again) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 031M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in September 2020, Fever (100 plus degree F) in September 2020 and Fever of unknown origin in 2020. Concurrent medical conditions included Hypertension. Concomitant products included LOVASTATIN for Cholesterol, TELMISARTAN for Hypertension.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced PYREXIA (Fever of 102 degrees F), ARTHRALGIA (Pain in joints), HEADACHE (Headache) and CHILLS (Chills). On an unknown date, the patient experienced COVID-19 (my adverse reaction was like having covid again). On 29-Jan-2021, PYREXIA (Fever of 102 degrees F), ARTHRALGIA (Pain in joints), HEADACHE (Headache) and CHILLS (Chills) had resolved. At the time of the report, COVID-19 (my adverse reaction was like having covid again) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2020, Chest X-ray: negative. In June 2020, Blood test: (Inconclusive) results not provided. In June 2020, Scan brain: (Inconclusive) result not provided. In October 2020, Computerised tomogram abdomen: (Inconclusive) reports not provided. In October 2020, Computerised tomogram thorax: (Inconclusive) reports not provided. On 27-Jan-2021, Body temperature: 102 102 degree F.         Treatment medication included Tylenol.   This case was linked to MOD-2021- (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up received on 19-APR-2021Information included Address , Race , Historical conditions , lab data , dosage number , concomitant medications.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen, Computerised tomogram thorax, Headache, Pyrexia, Scan brain
Clinical narrative: Fever of 102 degrees F; Pain in joints; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 102 degrees F), ARTHRALGIA (Pain in joints), HEADACHE (Headache), CHILLS (Chills) and COVID-19 (my adverse reaction was like having covid again) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 031M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in September 2020, Fever (100 plus degree F) in September 2020 and Fever of unknown origin in 2020. Concurrent medical conditions included Hypertension. Concomitant products included LOVASTATIN for Cholesterol, TELMISARTAN for Hypertension.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced PYREXIA (Fever of 102 degrees F), ARTHRALGIA (Pain in joints), HEADACHE (Headache) and CHILLS (Chills). On an unknown date, the patient experienced COVID-19 (my adverse reaction was like having covid again). On 29-Jan-2021, PYREXIA (Fever of 102 degrees F), ARTHRALGIA (Pain in joints), HEADACHE (Headache) and CHILLS (Chills) had resolved. At the time of the report, COVID-19 (my adverse reaction was like having covid again) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2020, Chest X-ray: negative. In June 2020, Blood test: (Inconclusive) results not provided. In June 2020, Scan brain: (Inconclusive) result not provided. In October 2020, Computerised tomogram abdomen: (Inconclusive) reports not provided. In October 2020, Computerised tomogram thorax: (Inconclusive) reports not provided. On 27-Jan-2021, Body temperature: 102 102 degree F.         Treatment medication included Tylenol.   This case was linked to MOD-2021- (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up received on 19-APR-2021Information included Address , Race , Historical conditions , lab data , dosage number , concomitant medications.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Pain at injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE PAIN (Pain at injection site) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Q3720A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced INJECTION SITE PAIN (Pain at injection site). On 27-Jan-2021, INJECTION SITE PAIN (Pain at injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter. No treatment medications provided by the reporter.   This case was linked to MOD-2021-211483 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Feb-2021: no new information for dose 1
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, SARS-CoV-2 test, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Swelling at injection site; Redness at injection site; Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site), MYALGIA (Body aches) and CHILLS (Chills) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 028L20A) for COVID-19 vaccination.     The patient's past medical history included SARS-CoV-2 infection on 08-Sep-2020. Concurrent medical conditions included Hypertension since August 2010, Hypothyroidism since June 2007, GERD since July 2002 and Hyperlipidemia since April 2012. Concomitant products included ESOMEPRAZOLE MAGNESIUM TRIHYDRATE (NEXIUM [ESOMEPRAZOLE MAGNESIUM TRIHYDRATE]) for GERD, ATENOLOL for Hypertension, LEVOTHYROXINE SODIUM (LEVOXYL) for Hypothyroidism.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced MYALGIA (Body aches) and CHILLS (Chills). On 30-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). On 30-Jan-2021, MYALGIA (Body aches) and CHILLS (Chills) had resolved. On 10-Feb-2021, VACCINATION SITE ERYTHEMA (Redness at injection site) had resolved. At the time of the report, VACCINATION SITE SWELLING (Swelling at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Sep-2020, SARS-CoV-2 test: positive (Positive) Positive.         Treatment medication information is not provided by the reporter. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Added second dose information, outcome of the event, medical history and concomitant medications dosage information.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Dyspepsia, Hyperhidrosis
Clinical narrative: CHESTPAIN; poor digestion; Light Headed; profusely sweating; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (CHESTPAIN), DYSPEPSIA (poor digestion), DIZZINESS (Light Headed) and HYPERHIDROSIS (profusely sweating) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced CHEST PAIN (CHESTPAIN), DYSPEPSIA (poor digestion), DIZZINESS (Light Headed) and HYPERHIDROSIS (profusely sweating). At the time of the report, CHEST PAIN (CHESTPAIN), DYSPEPSIA (poor digestion), DIZZINESS (Light Headed) and HYPERHIDROSIS (profusely sweating) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-261753 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: No new significant information for dose 1
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Eczema eyelids, Eyelids pruritus, Lacrimation increased, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Teary eyes; Red scaly eyelids; Itchy eyelids; Injection site redness; Injection site hot; Injection site very itchy; Injection site swelling; This spontaneous case was reported by a consumer and describes the occurrence of LACRIMATION INCREASED (Teary eyes), ECZEMA EYELIDS (Red scaly eyelids), EYELIDS PRURITUS (Itchy eyelids), VACCINATION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE WARMTH (Injection site hot) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Teary eyes, Eczema eyelids and Eyelids pruritus.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site very itchy) and VACCINATION SITE SWELLING (Injection site swelling). On an unknown date, the patient experienced LACRIMATION INCREASED (Teary eyes), ECZEMA EYELIDS (Red scaly eyelids) and EYELIDS PRURITUS (Itchy eyelids). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, LACRIMATION INCREASED (Teary eyes), ECZEMA EYELIDS (Red scaly eyelids), EYELIDS PRURITUS (Itchy eyelids), VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site very itchy) and VACCINATION SITE SWELLING (Injection site swelling) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: No new information was received.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Teary eyes; Red scaly eyelids; Itchy eyelids; Injection site redness; Injection site hot; Injection site very itchy; Injection site swelling; This spontaneous case was reported by a consumer and describes the occurrence of LACRIMATION INCREASED (Teary eyes), ECZEMA EYELIDS (Red scaly eyelids), EYELIDS PRURITUS (Itchy eyelids), VACCINATION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE WARMTH (Injection site hot) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Teary eyes, Eczema eyelids and Eyelids pruritus.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site very itchy) and VACCINATION SITE SWELLING (Injection site swelling). On an unknown date, the patient experienced LACRIMATION INCREASED (Teary eyes), ECZEMA EYELIDS (Red scaly eyelids) and EYELIDS PRURITUS (Itchy eyelids). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, LACRIMATION INCREASED (Teary eyes), ECZEMA EYELIDS (Red scaly eyelids), EYELIDS PRURITUS (Itchy eyelids), VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site very itchy) and VACCINATION SITE SWELLING (Injection site swelling) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: No new information was received.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Pain, Peripheral swelling, Vaccination site pain, Vaccination site warmth
Clinical narrative: Injection site was hot to touch; Left arm swollen; rash 2.5 inches in diameter; Injection site stung; Left arm sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Left arm sore), PERIPHERAL SWELLING (Left arm swollen), INJECTION SITE RASH (rash 2.5 inches in diameter), VACCINATION SITE WARMTH (Injection site was hot to touch) and VACCINATION SITE PAIN (Injection site stung) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN (Left arm sore). On 26-Jan-2021, the patient experienced PERIPHERAL SWELLING (Left arm swollen), INJECTION SITE RASH (rash 2.5 inches in diameter), VACCINATION SITE WARMTH (Injection site was hot to touch) and VACCINATION SITE PAIN (Injection site stung). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Jan-2021, PAIN (Left arm sore) had resolved. At the time of the report, PERIPHERAL SWELLING (Left arm swollen), INJECTION SITE RASH (rash 2.5 inches in diameter), VACCINATION SITE WARMTH (Injection site was hot to touch) and VACCINATION SITE PAIN (Injection site stung) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: TCR: Pt feels better, requesting no more follow ups
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cold sweat, Feeling abnormal, Headache, Myalgia
Clinical narrative: Feeling "clammy"; feels like crap, feeling yucky; Body ache; Low grade fever 99F; Headache; Nauseated; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (Feeling "clammy"), FEELING ABNORMAL (feels like crap, feeling yucky), MYALGIA (Body ache), PYREXIA (Low grade fever 99F) and HEADACHE (Headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Jan-2021 at 2:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced COLD SWEAT (Feeling "clammy"), FEELING ABNORMAL (feels like crap, feeling yucky), MYALGIA (Body ache), PYREXIA (Low grade fever 99F), HEADACHE (Headache) and NAUSEA (Nauseated). At the time of the report, COLD SWEAT (Feeling "clammy"), FEELING ABNORMAL (feels like crap, feeling yucky), MYALGIA (Body ache), PYREXIA (Low grade fever 99F), HEADACHE (Headache) and NAUSEA (Nauseated) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, Body temperature: 99 °F (Low) (99F).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.